Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

Targeted Oncology ◽

10.1007/s11523-010-0138-5 ◽

2010 ◽

Vol 5 (1) ◽

pp. 19-28 ◽

Cited By ~ 23

Author(s):

Andrea Sartore-Bianchi ◽

Katia Bencardino ◽

Federica Di Nicolantonio ◽

Federico Pozzi ◽

Chiara Funaioli ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Molecular Dissection ◽

Oncogenic Pathway ◽

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

Targeted Oncology ◽

10.1007/s11523-010-0142-9 ◽

2010 ◽

Vol 7 (4) ◽

pp. 267-267

Author(s):

Andrea Sartore-Bianchi ◽

Katia Bencardino ◽

Federica Di Nicolantonio ◽

Federico Pozzi ◽

Chiara Funaioli ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Molecular Dissection ◽

Oncogenic Pathway ◽

Clinical Use of Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.28.11-supp.31s ◽

2008 ◽

Vol 28 (11 Part 2) ◽

pp. 31S-41S ◽

Cited By ~ 21

Author(s):

Dina K Patel

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Clinical Use ◽

Location of Primary Tumor and Benefit From Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild‐Type Metastatic Colorectal Cancer

The Oncologist ◽

10.1634/theoncologist.2016-0084 ◽

2016 ◽

Vol 21 (8) ◽

pp. 988-994 ◽

Cited By ~ 42

Author(s):

Roberto Moretto ◽

Chiara Cremolini ◽

Daniele Rossini ◽

Filippo Pietrantonio ◽

Francesca Battaglin ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Primary Tumor ◽

Growth Factor Receptor ◽

Wild Type ◽

Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.28.6.742 ◽

2008 ◽

Vol 28 (6) ◽

pp. 742-754 ◽

Cited By ~ 56

Author(s):

Gary W Jean ◽

Sachin R Shah

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer

Cancer Genomics & Proteomics ◽

10.21873/cgp.20217 ◽

2020 ◽

Vol 17 (5) ◽

pp. 605-613 ◽

Cited By ~ 1

Author(s):

ONDREJ FIALA ◽

ONDREJ SOREJS ◽

PETR HOSEK ◽

VACLAV LISKA ◽

ONDREJ VYCITAL ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

First-Line Use of Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.3816/ccc.2007.s.001 ◽

2007 ◽

Vol 6 ◽

pp. S42-S46 ◽

Cited By ~ 9

Author(s):

James J. Lee ◽

Edward Chu

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

First Line ◽

Predictive and prognostic roles ofBRAFmutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A meta-analysis

Journal of Digestive Diseases ◽

10.1111/1751-2980.12063 ◽

2013 ◽

Vol 14 (8) ◽

pp. 409-416 ◽

Cited By ~ 25

Author(s):

Qi Xu ◽

An Tao Xu ◽

Ming Ming Zhu ◽

Jin Lu Tong ◽

Xi Tao Xu ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

What are the effects of epidermal growth factor receptor inhibitor monoclonal antibodies in people with RAS mutation metastatic colorectal cancer?

Cochrane Clinical Answers ◽

10.1002/cca.1867 ◽

2017 ◽

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Ras Mutation ◽

Epidermal Growth ◽

Receptor Inhibitor

Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

International Journal of Cancer ◽

10.1002/ijc.28153 ◽

2013 ◽

Vol 133 (8) ◽

pp. 1914-1925 ◽

Cited By ~ 51

Author(s):

Zu-Yao Yang ◽

Xin-Yin Wu ◽

Ya-Fang Huang ◽

Meng-Yang Di ◽

Da-Yong Zheng ◽

...

Keyword(s):

Colorectal Cancer ◽

Systematic Review ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽